Evolution of A(H1N1) pdm09 influenza virus masking by glycosylation
- PMID: 33756084
- DOI: 10.1080/14760584.2021.1908135
Evolution of A(H1N1) pdm09 influenza virus masking by glycosylation
Abstract
Introduction: As the pathogen that caused the first influenza virus pandemic in this century, the swine-origin A(H1N1) pdm09 influenza virus has caused continuous harm to human public health. The evolution of hemagglutinin protein glycosylation sites, including the increase in number and positional changes, is an important way for influenza viruses to escape host immune pressure. Based on the traditional influenza virus molecular monitoring, special attention should be paid to the influence of glycosylation evolution on the biological characteristics of virus antigenicity, transmission and pathogenicity. The epidemiological significance of glycosylation mutants should be analyzed as a predictive tool for early warning of new outbreaks and pandemics, as well as the design of vaccines and drug targets.Areas covered: We review on the evolutionary characteristics of glycosylation on the HA protein of the A(H1N1)pdm09 influenza virus in the last ten years.Expert opinion: We discuss the crucial impact of evolutionary glycosylation on the biological characteristics of the virus and the host immune responses, summarize studies revealing different roles of glycosylation play during host adaptation. Although these studies show the significance of glycosylation evolution in host-virus interaction, much remains to be discovered about the mechanism.
Keywords: Glycosylation; HA; influenza; mutation.
Similar articles
-
Variation in the HA antigenicity of A(H1N1)pdm09-related swine influenza viruses.J Gen Virol. 2021 Mar;102(3). doi: 10.1099/jgv.0.001569. Epub 2021 Feb 22. J Gen Virol. 2021. PMID: 33616517
-
Evolution and dynamics of the pandemic H1N1 influenza hemagglutinin protein from 2009 to 2017.Arch Virol. 2018 Nov;163(11):3035-3049. doi: 10.1007/s00705-018-3962-z. Epub 2018 Jul 31. Arch Virol. 2018. PMID: 30066273
-
Evolution of the hemagglutinin expressed by human influenza A(H1N1)pdm09 and A(H3N2) viruses circulating between 2008-2009 and 2013-2014 in Germany.Int J Med Microbiol. 2015 Oct;305(7):762-75. doi: 10.1016/j.ijmm.2015.08.030. Epub 2015 Aug 21. Int J Med Microbiol. 2015. PMID: 26416089
-
[Advances in the structure and function of pandemic A/H1N1/2009 influenza virus HA protein].Bing Du Xue Bao. 2012 Jun;28(4):444-52. Bing Du Xue Bao. 2012. PMID: 22978172 Review. Chinese.
-
Emergence and pandemic potential of swine-origin H1N1 influenza virus.Nature. 2009 Jun 18;459(7249):931-9. doi: 10.1038/nature08157. Nature. 2009. PMID: 19525932 Free PMC article. Review.
Cited by
-
SERINC5 restricts influenza virus infectivity.PLoS Pathog. 2022 Oct 12;18(10):e1010907. doi: 10.1371/journal.ppat.1010907. eCollection 2022 Oct. PLoS Pathog. 2022. PMID: 36223419 Free PMC article.
-
Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants.Emerg Microbes Infect. 2021 Dec;10(1):1519-1529. doi: 10.1080/22221751.2021.1957720. Emerg Microbes Infect. 2021. PMID: 34278967 Free PMC article.
-
Virus versus host: influenza A virus circumvents the immune responses.Front Microbiol. 2024 May 16;15:1394510. doi: 10.3389/fmicb.2024.1394510. eCollection 2024. Front Microbiol. 2024. PMID: 38817972 Free PMC article. Review.
-
Pseudotyped Viruses for Lyssavirus.Adv Exp Med Biol. 2023;1407:191-208. doi: 10.1007/978-981-99-0113-5_10. Adv Exp Med Biol. 2023. PMID: 36920698
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials